Search Results - "LIU, Tommy F"

Refine Results
  1. 1

    Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation by Liu, Tommy F., Shafer, Robert W.

    Published in Clinical infectious diseases (01-06-2006)
    “…Interpreting the results of plasma human immunodeficiency virus type 1 (HIV-1) genotypic drug-resistance tests is one of the most difficult tasks facing…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool by WOODS, Conan K, BRUMME, Chanson J, LIU, Tommy F, CHUI, Celia K. S, CHU, Anna L, WYNHOVEN, Brian, HALL, Tom A, TREVINO, Christina, SHAFER, Robert W, HARRIGAN, P. Richard

    Published in Journal of Clinical Microbiology (01-06-2012)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    The HIVdb system for HIV-1 genotypic resistance interpretation by Tang, Michele W, Liu, Tommy F, Shafer, Robert W

    Published in Intervirology (01-01-2012)
    “…The Stanford HIV Drug Resistance Database hosts a freely available online genotypic resistance interpretation system called HIVdb to help clinicians and…”
    Get more information
    Journal Article
  5. 5
  6. 6

    The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance by Gifford, Robert J., Liu, Tommy F., Rhee, Soo-Yon, Kiuchi, Mark, Hue, Stephane, Pillay, Deenan, Shafer, Robert W.

    Published in Bioinformatics (01-05-2009)
    “…The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug…”
    Get full text
    Journal Article
  7. 7

    Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens by Van Zyl, Gert U, Liu, Tommy F, Claassen, Mathilda, Engelbrecht, Susan, de Oliveira, Tulio, Preiser, Wolfgang, Wood, Natasha T, Travers, Simon, Shafer, Robert W

    Published in PloS one (26-06-2013)
    “…South Africa's national antiretroviral (ARV) treatment program expanded in 2010 to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI)…”
    Get full text
    Journal Article
  8. 8

    Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors by Rhee, Soo-Yon, Liu, Tommy F, Kiuchi, Mark, Zioni, Rafael, Gifford, Robert J, Holmes, Susan P, Shafer, Robert W

    Published in Retrovirology (07-08-2008)
    “…HIV-1 integrase is the third enzymatic target of antiretroviral (ARV) therapy. However, few data have been published on the distribution of naturally occurring…”
    Get full text
    Journal Article
  9. 9

    Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing by Margeridon-Thermet, Severine, Le Pogam, Sophie, Li, Lewyn, Liu, Tommy F, Shulman, Nancy, Shafer, Robert W, Najera, Isabel

    Published in PloS one (20-08-2014)
    “…Hepatitis C virus (HCV) variants that confer resistance to direct-acting-antiviral agents (DAA) have been detected by standard sequencing technology in…”
    Get full text
    Journal Article
  10. 10

    Minority Human Immunodeficiency Virus Type 1 Variants in Antiretroviral-Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations by MITSUYA, Yumi, VARGHESE, Vici, SHAFER, Robert W, CHUNLIN WANG, LIU, Tommy F, HOLMES, Susan P, JAYAKUMAR, Prerana, GHARIZADEH, Baback, RONAGHI, Mostafa, KLEIN, Daniel, FESSEL, W. Jeffrey

    Published in Journal of Virology (01-11-2008)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1 by VARGHESE, Vici, MITSUYA, Yumi, FESSEL, W. Jeffrey, LIU, Tommy F, MELIKIAN, George L, KATZENSTEIN, David A, SCHIFFER, Celia A, HOLMES, Susan P, SHAFER, Robert W

    Published in Antimicrobial Agents and Chemotherapy (01-09-2013)
    “…OA  Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12
  13. 13

    HIV-1 subtype B protease and reverse transcriptase amino acid covariation by Rhee, Soo-Yon, Liu, Tommy F, Holmes, Susan P, Shafer, Robert W

    Published in PLoS computational biology (01-05-2007)
    “…Despite the high degree of HIV-1 protease and reverse transcriptase (RT) mutation in the setting of antiretroviral therapy, the spectrum of possible virus…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations by SHAHRIAR, Rajin, RHEE, Soo-Yon, LIU, Tommy F, FESSEL, W. Jeffrey, SCARSELLA, Anthony, TOWNER, William, HOLMES, Susan P, ZOLOPA, Andrew R, SHAFER, Robert W

    Published in Antimicrobial Agents and Chemotherapy (01-11-2009)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Prevalence of Darunavir Resistance-Associated Mutations: Patterns of Occurrence and Association with Past Treatment by Mitsuya, Yumi, Liu, Tommy F., Rhee, Soo-Yon, Fessel, W. Jeffrey, Shafer, Robert W.

    Published in The Journal of infectious diseases (15-10-2007)
    “…Eleven protease mutations have been associated with reduced susceptibility to darunavir (DRV). We examined the prevalence and covariates of these mutations in…”
    Get full text
    Journal Article
  17. 17

    Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes by Rhee, Soo-Yon, Blanco, Jose Luis, Liu, Tommy F, Pere, Iñaki, Kaiser, Rolf, Zazzi, Maurizio, Incardona, Francesca, Towner, William, Gatell, Josep Maria, De Luca, Andrea, Fessel, W Jeffrey, Shafer, Robert W

    Published in AIDS research and therapy (03-05-2012)
    “…To identify the determinants of successful antiretroviral (ARV) therapy, researchers study the virological responses to treatment-change episodes (TCEs)…”
    Get full text
    Journal Article
  18. 18

    Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery by Rhee, Soo-Yon, Margeridon-Thermet, Severine, Nguyen, Mindie H., Liu, Tommy F., Kagan, Ron M., Beggel, Bastian, Verheyen, Jens, Kaiser, Rolf, Shafer, Robert W.

    Published in Antiviral research (01-12-2010)
    “…Drug resistance resulting from reverse transcriptase (RT) mutations is one of the main obstacles to successful hepatitis B virus (HBV) therapy. Indeed, HBV…”
    Get full text
    Journal Article
  19. 19

    Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance by Babrzadeh, Farbod, Varghese, Vici, Pacold, Mary, Liu, Tommy F, Nyrén, Pål, Schiffer, Celia, Fessel, W Jeffrey, Shafer, Robert W

    Published in Journal of antimicrobial chemotherapy (01-02-2013)
    “…To determine whether pan-protease inhibitor (PI)-resistant virus populations are composed predominantly of viruses with resistance to all PIs or of diverse…”
    Get full text
    Journal Article
  20. 20

    HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir by Varghese, Vici, Liu, Tommy F, Rhee, Soo-Yon, Libiran, Paolo, Trevino, Christina, Fessel, W Jeffrey, Shafer, Robert W

    Published in AIDS research and human retroviruses (01-12-2010)
    “…Viruses were sequenced from 75 antiretroviral therapy (ARV)-naïve and from 75 ARV-treated patients who subsequently received a raltegravir-containing regimen…”
    Get more information
    Journal Article